531 |
Impact of Ischemic vs. Bleeding Endpoints: Lessons from ACUITY and HORIZONS |
Roxana Mehran |
Jul. 21. 09 |
530 |
European Consensus for Bifurcation PCI |
Thierry Lefevre |
Jul. 21. 09 |
529 |
Very Long-Term Outcomes of Left Main DES |
Alaide Chieffo |
Jul. 21. 09 |
528 |
Lessons from the CACTUS Trial |
Alaide Chieffo |
Jul. 21. 09 |
527 |
HORIZONS AMI: A Large Prospective Randomized Trial of PES vs. BMS in Patients with STEMI |
Gregg W. Stone |
Jul. 21. 09 |
526 |
Perspectives on the Use of Fondaparinux in ACS: Transitioning to the Cath Lab |
Ron Waksman |
Jul. 21. 09 |
525 |
Acute Myocardial Infarction - Expanding the Therapeutic Paradigm |
Howard A. Cohen |
Jul. 21. 09 |
524 |
MULTI-STRATEGY: Tirofiban vs. Abciximab During Primary PCI in STEMI |
Marco Valgimigli |
Jul. 21. 09 |
523 |
ON-TIME-2: Early Administration of Tirofiban During Primary PCI in STEMI |
Harry Suryapranata |
Jul. 21. 09 |
522 |
Thrombectomy in AMI- Perspectives on a Hot Topic |
On Topaz |
Jul. 21. 09 |